Approvals/TGA/SITAGLIPTIN/METFORMIN MYLAN 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack

Approved

STANDARD

SITAGLIPTIN/METFORMIN MYLAN 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack

Maple Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: fe5ca03b12db21cb
Company: Maple Healthcare Pty Ltd
Type: Standard

Approval Details

Approval Id: fe5ca03b12db21cb
Product Name: SITAGLIPTIN/METFORMIN MYLAN 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack
Artg Id: 386881
Artg Name: SITAGLIPTIN/METFORMIN MYLAN 50/850 sitagliptin (as hydrochloride monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack
Sponsor: Maple Healthcare Pty Ltd
Company Detail Path: /organization/maple-healthcare-pty-ltd
Artg Date: 2023-04-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c058ac090026a37d7aa0700fa4d85b58.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7e0b0d33a00ad00502a8048a75900c8c.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

fe5ca03b12db21cb

Type

Standard

Back to TGA Approvals